Avammune
3 known investors
Avammune is a drug discovery company developing novel therapeutics for hard-to-treat solid tumors using computational chemistry, immunology, and targeted radiotherapeutics. The company focuses on converting immunologically cold tumors into responsive ones and identifying new cancer dependencies as therapeutic targets.
Investors · 3
Frequently asked questions
- What does Avammune do?
- Avammune is a drug discovery company developing novel therapeutics for hard-to-treat solid tumors using computational chemistry, immunology, and targeted radiotherapeutics. The company focuses on converting immunologically cold tumors into responsive ones and identifying new cancer dependencies as therapeutic targets.
- Who are Avammune's investors?
- Avammune's investors include 1Crowd, Capital2B, Shastra VC.